Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 200 Total
MCRB - Seres Therapeutics Inc - Stock Price Chart
TickerMCRB [NASD]
CompanySeres Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap89.25MEPS (ttm)-9.99
P/E-EPS this Y-
Forward P/E-EPS next Y-746.32%
PEG-EPS past 5Y5.33%
P/S-EPS next 5Y-
P/B1.77EPS Q/Q168.26%
Dividend-Sales Q/Q-
Insider Own26.28%Inst Own21.98%
Insider Trans-1.26%Inst Trans-43.19%
Short Float10.55%EarningsMay 07/b
Analyst Recom2.60Target Price13.33
Avg Volume107.18K52W Range6.53 - 30.60
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young Teresa L.See RemarksMay 16 '25Sale7.28634595,044May 19 04:05 PM
Shaff Eric D.CEO and PresidentMay 16 '25Sale7.282201,60210,102May 19 04:05 PM
DesRosier ThomasChief Legal Officer and EVPMay 15 '25Sale7.28795757,287May 19 04:05 PM
Henn Matthew RSee RemarksMay 16 '25Sale7.28775614,383May 19 04:05 PM
Young Teresa L.See RemarksFeb 18 '25Sale0.813,3382,70497,536Feb 19 08:11 PM
RADX - Radiopharm Theranostics Ltd ADR - Stock Price Chart
TickerRADX [NASD]
CompanyRadiopharm Theranostics Ltd ADR
CountryAustralia
IndustryBiotechnology
Market Cap33.65MEPS (ttm)-12.28
P/E-EPS this Y87.08%
Forward P/E-EPS next Y20.03%
PEG-EPS past 5Y-
P/S30.31EPS next 5Y53.55%
P/B0.95EPS Q/Q85.67%
Dividend-Sales Q/Q-
Insider Own-Inst Own4.35%
Insider Trans-Inst Trans-99.87%
Short Float-EarningsFeb 28/a
Analyst Recom1.00Target Price16.36
Avg Volume23.91K52W Range3.50 - 50.82
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.
SMR - NuScale Power Corporation - Stock Price Chart
TickerSMR [NYSE, RUT]
CompanyNuScale Power Corporation
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap10.36BEPS (ttm)-1.37
P/E-EPS this Y78.30%
Forward P/E-EPS next Y22.42%
PEG-EPS past 5Y-34.24%
P/S211.23EPS next 5Y59.81%
P/B6.88EPS Q/Q47.31%
Dividend-Sales Q/Q869.91%
Insider Own10.59%Inst Own54.01%
Insider Trans-3.45%Inst Trans8.30%
Short Float20.99%EarningsMay 12/a
Analyst Recom2.18Target Price34.66
Avg Volume11.82M52W Range6.88 - 45.31
NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by Jose N. Reyes in 2007 and is headquartered in Corvallis, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hamady Robert RamseyChief Financial OfficerMay 30 '25Option Exercise3.2040,000128,00040,001Jun 02 04:02 PM
Hamady Robert RamseyChief Financial OfficerMay 30 '25Sale32.1069,9842,246,4861Jun 02 04:02 PM
Hamady Robert RamseyOfficerMay 30 '25Proposed Sale32.1069,9842,246,486May 30 11:53 AM
Hopkins John LawrenceChief Executive OfficerMay 15 '25Sale23.6626,345623,3750May 16 05:43 PM
Hopkins John LawrenceOfficerMay 15 '25Proposed Sale23.6626,345623,368May 15 02:05 PM
AMZE - Amaze Holdings Inc - Stock Price Chart
TickerAMZE [AMEX]
CompanyAmaze Holdings Inc
CountryUSA
IndustryBeverages - Wineries & Distilleries
Market Cap40.97MEPS (ttm)-5.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-38.47%
P/S163.89EPS next 5Y-
P/B0.08EPS Q/Q-65.07%
Dividend-Sales Q/Q-42.42%
Insider Own32.29%Inst Own0.38%
Insider Trans4.52%Inst Trans-
Short Float0.24%Earnings-
Analyst Recom-Target Price-
Avg Volume26.91K52W Range5.78 - 28.72
Amaze Holdings, Inc. produces low carb and calorie premium wines. Its varietals currently include Cabernet Sauvignon, Chardonnay, Pinot Noir and Rose. The firm sales channels include wholesale, retail, and direct-to-consumer (DTC) channels able to conduct wholesale distribution of wine in all 50 states and Puerto Rico. Its wholesale distribution network includes 30 distributors, including a distribution agreement with Southern Glazer's Wine and Spirits. The company was founded by Julianne Hough, Nina Dobrev, Rick Nechio and Damian Novak in May 2019 and is headquartered in Newport Beach, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Day AaronDirectorJun 10 '25Buy0.4473,71632,22173,716Jun 12 06:39 PM
ACHR - Archer Aviation Inc - Stock Price Chart
TickerACHR [NYSE, RUT]
CompanyArcher Aviation Inc
CountryUSA
IndustryAerospace & Defense
Market Cap6.34BEPS (ttm)-1.24
P/E-EPS this Y32.59%
Forward P/E-EPS next Y-3.15%
PEG-EPS past 5Y-60.86%
P/S-EPS next 5Y15.95%
P/B5.43EPS Q/Q52.50%
Dividend-Sales Q/Q-
Insider Own18.59%Inst Own33.42%
Insider Trans-0.70%Inst Trans4.79%
Short Float12.77%EarningsMay 12/a
Analyst Recom1.67Target Price12.28
Avg Volume33.28M52W Range2.82 - 13.92
Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lentell EricOfficerJun 30 '25Proposed Sale10.6095,8961,016,498Jun 30 10:36 AM
Diaz Fred MDirectorJun 21 '25Option Exercise0.0054,6440107,355Jun 24 08:45 PM
Spellacy MichaelDirectorJun 21 '25Option Exercise0.0054,644054,644Jun 24 08:07 PM
Pinelli MariaDirectorJun 21 '25Option Exercise0.0054,6440182,685Jun 24 08:06 PM
MUNOZ OSCARDirectorJun 21 '25Option Exercise0.0054,6440442,121Jun 24 08:03 PM
KNW - Know Labs Inc - Stock Price Chart
TickerKNW [AMEX]
CompanyKnow Labs Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap13.69MEPS (ttm)-6.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y14.18%
P/S-EPS next 5Y-
P/B-EPS Q/Q53.95%
Dividend-Sales Q/Q-
Insider Own29.90%Inst Own0.46%
Insider Trans0.00%Inst Trans-60.02%
Short Float17.00%EarningsFeb 14/a
Analyst Recom1.00Target Price40.00
Avg Volume5.53M52W Range0.33 - 20.00
Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. It offers its product under the ChromaID brand. The firm operates through the following segments: The Development of Bio-RFID and ChromaID Technology, Particle, Inc. Technology, and AI Sales of NFT Products. Know Labs was founded by Ronald Peter Erickson on October 8, 1998 and is headquartered in Seattle, WA.
KYTX - Kyverna Therapeutics Inc - Stock Price Chart
TickerKYTX [NASD, RUT]
CompanyKyverna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap122.31MEPS (ttm)-3.37
P/E-EPS this Y-11.70%
Forward P/E-EPS next Y15.42%
PEG-EPS past 5Y-
P/S-EPS next 5Y-2.34%
P/B0.55EPS Q/Q8.09%
Dividend-Sales Q/Q-
Insider Own54.98%Inst Own25.51%
Insider Trans0.00%Inst Trans-15.72%
Short Float10.79%EarningsMay 13/a
Analyst Recom1.00Target Price17.20
Avg Volume397.88K52W Range1.78 - 11.40
Jun-30-25 09:00AM Kyverna Therapeutics Announces Appointment of New Chief Financial Officer (PR Newswire) -6.40%
May-28-25 04:02PM Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference (PR Newswire)
May-16-25 06:36AM Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff (BioPharma Dive) +6.42%
May-13-25 04:02PM Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results (PR Newswire) -7.33%
Apr-17-25 07:38AM Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your Behalf (GlobeNewswire)
Mar-27-25 04:02PM Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -5.80% -15.07%
Mar-24-25 09:13AM Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is Investigating Claims on Your Behalf (GlobeNewswire)
Mar-21-25 11:29AM Kyverna: 2 Myasthenia Gravis Program Catalysts On Deck In 2025 (SeekingAlpha)
08:32AM Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Rocket Lab USA, Inc. (NASDAQ: RKLB): Grabar Law Office is Investigating Claims on Your Behalf (GlobeNewswire)
Mar-18-25 04:48PM Notice to Long-Term Shareholders of Archer-Daniels-Midland Co. (NYSE: ADM); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Kyverna Therapeutics, Inc. (Nasdaq: KYTX); and Mercury Systems, Inc. (Nasdaq: MRCY): Grabar Law Office is Investigating Claims on Your Behalf (GlobeNewswire)
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
OS - OneStream Inc - Stock Price Chart
TickerOS [NASD]
CompanyOneStream Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap6.25BEPS (ttm)-1.44
P/E-EPS this Y-23.56%
Forward P/E103.24EPS next Y136.22%
PEG-EPS past 5Y-
P/S12.13EPS next 5Y44.91%
P/B11.13EPS Q/Q-344.66%
Dividend-Sales Q/Q23.59%
Insider Own59.79%Inst Own38.52%
Insider Trans-0.35%Inst Trans14.15%
Short Float6.46%EarningsMay 08/a
Analyst Recom1.30Target Price31.32
Avg Volume1.31M52W Range16.69 - 35.39
OneStream, Inc. is a holding company, which engages in the development of an artificial intelligence (AI) based enterprise finance platform. The firm offers Digital Finance Cloud, an AI-enabled and extensible software platform that unifies core financial functions and operational data and processes. The company was founded by Craig Colby and Thomas Shea on October 15, 2021 and is headquartered in Birmingham, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Koefoed William AChief Financial OfficerJun 25 '25Option Exercise10.6525,000266,250262,839Jun 27 04:26 PM
Koefoed William AChief Financial OfficerJun 25 '25Sale26.7725,000669,250237,839Jun 27 04:26 PM
Koefoed William AOfficerJun 25 '25Proposed Sale26.7725,000669,250Jun 25 10:25 AM
Kinzer JohnDirectorJun 20 '25Sale28.2630,000847,8270Jun 24 04:29 PM
Hohenstein KenChief Revenue OfficerJun 18 '25Option Exercise10.6520,000213,0001,023,163Jun 23 04:48 PM
LEU - Centrus Energy Corp - Stock Price Chart
TickerLEU [AMEX, RUT]
CompanyCentrus Energy Corp
CountryUSA
IndustryUranium
Market Cap2.88BEPS (ttm)6.38
P/E26.50EPS this Y-17.60%
Forward P/E54.01EPS next Y-15.02%
PEG-EPS past 5Y-
P/S6.11EPS next 5Y-9.44%
P/B13.46EPS Q/Q516.04%
Dividend-Sales Q/Q67.28%
Insider Own8.31%Inst Own74.74%
Insider Trans-0.66%Inst Trans7.41%
Short Float21.02%EarningsMay 07/a
Analyst Recom1.64Target Price176.50
Avg Volume1.11M52W Range33.51 - 211.31
Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HARRILL KEVIN JCFO & TreasurerMay 30 '25Sale126.001,728217,7280Jun 02 04:17 PM
Donelson John M ASVP, Sales & Chief Mktg OffMay 13 '25Sale96.313,732359,4290May 15 12:01 PM
CUTLIP LARRY BSVP, FIELD OPERATIONSFeb 12 '25Sale120.314,000481,2409,402Feb 13 02:39 PM
VEXLER AMIR VADIMPRESIDENT & CEODec 04 '24Option Exercise0.004,00004,000Dec 06 03:30 PM
CUTLIP LARRY BSVP, FIELD OPERATIONSAug 13 '24Sale37.643,000112,92013,402Aug 15 03:53 PM
HSDT - Helius Medical Technologies Inc - Stock Price Chart
TickerHSDT [NASD]
CompanyHelius Medical Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap0.09MEPS (ttm)-2390.32
P/E-EPS this Y92.20%
Forward P/E-EPS next Y74.56%
PEG-EPS past 5Y63.29%
P/S0.20EPS next 5Y-
P/B0.05EPS Q/Q83.50%
Dividend-Sales Q/Q-63.70%
Insider Own5.46%Inst Own77.83%
Insider Trans0.00%Inst Trans0.79%
Short Float467.08%EarningsMay 08
Analyst Recom1.00Target Price3000.00
Avg Volume125.91K52W Range8.51 - 1200.00
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
1456789101112131420